Exonova Biotech is redefining the diagnostic pathway for endometriosis. The current gold standard is invasive laparoscopic surgery, a process that is outdated, risky, and costly. We’re moving the diagnosis from the operating theater to the pathology lab. By combining a proprietary biomarker panel with a high-precision analytical model, Exonova replaces surgical guesswork with data-driven precision, delivering a clinically actionable result and getting patients the right care years sooner.

EXONOVA Biotech

Org chart

Teams

Offices